The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
ReWalk Robotics 
General Information
Business: We are an innovative medical device company that is designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. We have developed and are continuing to commercialize ReWalk, an exoskeleton that uses our patented tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. Current ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. We currently offer two products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by individuals at home and in their communities, and is custom-fit for each user. ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides valuable exercise and therapy. It also enables individuals to evaluate their capacity for using ReWalk Personal in the future.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Employees: 63 Founded: 2001
Contact Information
Address: Kochav Yokneam Building, Floor 6, Yokneam Ilit 20692, Israel
Phone: 972-4- 959 0123
Web Address:
View Prospectus: ReWalk Robotics
Financial Information
Market Cap: $ 172.8 mil
Revenues: $ 1.7 mil (last 12 months)
Net Income: $ -16.5 mil (last 12 months)
IPO Profile
Symbol: RWLK
Shares (millions): 3.0
Price Range: $12.00 - $12.00
Est.$ Volume $ 36.0 mil
Manager / Joint Managers Barclays/ Jefferies
Co Managers Canaccord Genuity
Expected to Trade 9/12/2014
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.